Site icon Scientific Inquirer

POLL: Does having an anti-viral COVID-19 drug available make you less likely to get vaccinated in the future?

tablets in pink background

Photo by Tara Winstead on Pexels.com

In a potential drug development game-changer, a major advance in combating Covid-19 has shown great promise in clinical trials. Per the Associated Press, “Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared, the drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorized in the U.S. require an IV or injection.” Normally, treatments that transition from needle vaccinations to pill form gain wider adoption by the public, not to mention greater profits for the company that develops it. https://bit.ly/3mjbsqy


A Single “First Mover” Can Set an Entire Ant Colony in Motion, Model Suggests
A computational model from NYU and NJIT researchers suggests synchronized bursts of …
Vision, Not the Frontal Lobe, Drove the Growth of the Primate Brain, Fossil Study Suggests
Virtual casts of living and fossil primate brains show visual regions expanding …
A Deadly Hospital Fungus Hides in Hair Follicles by Turning the Skin’s Defenses Down
Candida auris exposes chitin in its cell wall, triggering an immune signal …
Scrapping a Working Gas Car for an EV Can Still Cut Emissions, Study Finds
A life-cycle analysis finds that replacing a functioning gasoline vehicle with an …

Exit mobile version